|
Volumn 40, Issue 1042, 1998, Pages 117-122
|
Choice of lipid-lowering drugs
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
BEZAFIBRATE;
CERIVASTATIN;
CLOFIBRATE;
COLESTIPOL;
COLESTYRAMINE;
ERYTHROMYCIN;
ESTROGEN;
FENOFIBRATE;
FIBRIC ACID DERIVATIVE;
FISH OIL;
FLUINDOSTATIN;
GEMFIBROZIL;
GESTAGEN;
HORMONE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ITRACONAZOLE;
KETOCONAZOLE;
LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
NICOTINIC ACID;
OMEGA 3 FATTY ACID;
PRAVASTATIN;
PREVALITE;
RESIN;
SIMVASTATIN;
STATIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CHOLESTEROL BLOOD LEVEL;
DRUG COST;
DRUG SAFETY;
DRUG TOLERABILITY;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HYPERLIPIDEMIA;
LIPOPROTEIN BLOOD LEVEL;
MYALGIA;
RASH;
REVIEW;
VISUAL DISORDER;
ANIMALS;
ANTILIPEMIC AGENTS;
CHOLESTYRAMINE;
CORONARY DISEASE;
ESTROGEN REPLACEMENT THERAPY;
GEMFIBROZIL;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPOPROTEINS;
NIACIN;
|
EID: 0032545435
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (25)
|
References (0)
|